Solvates, salts, and cocrystals

a proposal for a feasible classification system

E. Grothe, H. Meekes, E. Vlieg, J. H. Ter Horst, R. De Gelder

Research output: Contribution to journalArticle

59 Citations (Scopus)
28 Downloads (Pure)

Abstract

The design of pharmaceutical cocrystals has initiated widespread debate on the classification of cocrystals. Current attempts to classify multicomponent crystals suffer from ambiguity, which has led to inconsistent definitions for cocrystals and for multicomponent crystals in general. Inspired by the work of Aitipamula et al. (Cryst. Growth Des. 2012, 12, 2147-2152), we present a feasible classification system for all multicomponent crystals. The present classification enables us to analyze and classify multicomponent crystal structures present in the Cambridge Structural Database (CSD). This reveals that all seven classes proposed are relevant in terms of frequency of occurrence. Lists of CSD refcodes for all classes are provided. We identified over 5000 cocrystals in the CSD, as well as over 12 000 crystals with more than two components. This illustrates that the possibilities for alternative drug formulations can be increased significantly by considering more than two components in drug design.

Original languageEnglish
Pages (from-to)3237-3243
Number of pages7
JournalCrystal Growth and Design
Volume16
Issue number6
Early online date21 Apr 2016
DOIs
Publication statusPublished - 1 Jun 2016

Fingerprint

proposals
Salts
salts
Crystals
crystals
drugs
Pharmaceutical Preparations
lists
ambiguity
Drug products
Crystal structure
occurrences
formulations
crystal structure

Keywords

  • solvates
  • crystal structures
  • salts

Cite this

Grothe, E. ; Meekes, H. ; Vlieg, E. ; Ter Horst, J. H. ; De Gelder, R. / Solvates, salts, and cocrystals : a proposal for a feasible classification system. In: Crystal Growth and Design . 2016 ; Vol. 16, No. 6. pp. 3237-3243.
@article{75a7142becb04ffeb97736b46a74e992,
title = "Solvates, salts, and cocrystals: a proposal for a feasible classification system",
abstract = "The design of pharmaceutical cocrystals has initiated widespread debate on the classification of cocrystals. Current attempts to classify multicomponent crystals suffer from ambiguity, which has led to inconsistent definitions for cocrystals and for multicomponent crystals in general. Inspired by the work of Aitipamula et al. (Cryst. Growth Des. 2012, 12, 2147-2152), we present a feasible classification system for all multicomponent crystals. The present classification enables us to analyze and classify multicomponent crystal structures present in the Cambridge Structural Database (CSD). This reveals that all seven classes proposed are relevant in terms of frequency of occurrence. Lists of CSD refcodes for all classes are provided. We identified over 5000 cocrystals in the CSD, as well as over 12 000 crystals with more than two components. This illustrates that the possibilities for alternative drug formulations can be increased significantly by considering more than two components in drug design.",
keywords = "solvates, crystal structures, salts",
author = "E. Grothe and H. Meekes and E. Vlieg and {Ter Horst}, {J. H.} and {De Gelder}, R.",
note = "This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.",
year = "2016",
month = "6",
day = "1",
doi = "10.1021/acs.cgd.6b00200",
language = "English",
volume = "16",
pages = "3237--3243",
journal = "Crystal Growth and Design",
issn = "1528-7483",
publisher = "American Chemical Society",
number = "6",

}

Solvates, salts, and cocrystals : a proposal for a feasible classification system. / Grothe, E.; Meekes, H.; Vlieg, E.; Ter Horst, J. H.; De Gelder, R.

In: Crystal Growth and Design , Vol. 16, No. 6, 01.06.2016, p. 3237-3243.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Solvates, salts, and cocrystals

T2 - a proposal for a feasible classification system

AU - Grothe, E.

AU - Meekes, H.

AU - Vlieg, E.

AU - Ter Horst, J. H.

AU - De Gelder, R.

N1 - This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The design of pharmaceutical cocrystals has initiated widespread debate on the classification of cocrystals. Current attempts to classify multicomponent crystals suffer from ambiguity, which has led to inconsistent definitions for cocrystals and for multicomponent crystals in general. Inspired by the work of Aitipamula et al. (Cryst. Growth Des. 2012, 12, 2147-2152), we present a feasible classification system for all multicomponent crystals. The present classification enables us to analyze and classify multicomponent crystal structures present in the Cambridge Structural Database (CSD). This reveals that all seven classes proposed are relevant in terms of frequency of occurrence. Lists of CSD refcodes for all classes are provided. We identified over 5000 cocrystals in the CSD, as well as over 12 000 crystals with more than two components. This illustrates that the possibilities for alternative drug formulations can be increased significantly by considering more than two components in drug design.

AB - The design of pharmaceutical cocrystals has initiated widespread debate on the classification of cocrystals. Current attempts to classify multicomponent crystals suffer from ambiguity, which has led to inconsistent definitions for cocrystals and for multicomponent crystals in general. Inspired by the work of Aitipamula et al. (Cryst. Growth Des. 2012, 12, 2147-2152), we present a feasible classification system for all multicomponent crystals. The present classification enables us to analyze and classify multicomponent crystal structures present in the Cambridge Structural Database (CSD). This reveals that all seven classes proposed are relevant in terms of frequency of occurrence. Lists of CSD refcodes for all classes are provided. We identified over 5000 cocrystals in the CSD, as well as over 12 000 crystals with more than two components. This illustrates that the possibilities for alternative drug formulations can be increased significantly by considering more than two components in drug design.

KW - solvates

KW - crystal structures

KW - salts

UR - http://www.scopus.com/inward/record.url?scp=84973312276&partnerID=8YFLogxK

U2 - 10.1021/acs.cgd.6b00200

DO - 10.1021/acs.cgd.6b00200

M3 - Article

VL - 16

SP - 3237

EP - 3243

JO - Crystal Growth and Design

JF - Crystal Growth and Design

SN - 1528-7483

IS - 6

ER -